Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-17 Sale | 2021-08-19 5:49 pm | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 14,779 | $47.56 | $702,889 | 72,021 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-16 Exercise | 2022-11-17 6:24 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer | 13,767 | $0.87 | 167,590 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-17 6:24 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer | 35,656 | $1.16 | 167,590 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-17 6:24 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer | 35,331 | $4.21 | 167,590 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-17 6:24 pm | N/A 2023-09-26 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer | 100,479 | $0 | 167,590 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-17 6:24 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer | 15,725 | $1.89 | 167,590 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-03-02 8:38 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 2,119 | $24.28 | 66,538 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:25 pm | N/A 2032-02-14 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 70,000 | $0 | 128,657 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 5:49 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 10,000 | $0.87 | 72,021 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 5:49 pm | N/A 2023-09-26 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 10,000 | $0 | 72,021 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:31 pm | N/A 2031-02-25 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 75,000 | $0 | 127,427 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 5:46 pm | N/A 2030-02-27 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 70,000 | $0 | 70,000 (Direct) | View |